Skip to main content
BrainsWay Ltd. (TLV:BWAY)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
3,869.00
-154.00 (-3.83%)
At close: Mar 9, 2026

BrainsWay Revenue

BrainsWay had revenue of $13.51M USD in the quarter ending September 30, 2025, with 28.66% growth. This brings the company's revenue in the last twelve months to $49.09M, up 27.08% year-over-year. In the year 2024, BrainsWay had annual revenue of $41.02M with 29.04% growth.

Revenue (ttm)
$49.09M
Revenue Growth
+27.08%
P/S Ratio
9.71
Revenue / Employee
$409.12K
Employees
120
Market Cap
1.58B ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202441.02M9.23M29.04%
Dec 31, 202331.79M4.61M16.96%
Dec 31, 202227.18M-2.48M-8.36%
Dec 31, 202129.66M7.60M34.46%
Dec 31, 202022.06M-1.04M-4.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 55.02B
Danel (Adir Yeoshua) 2.87B
Kamada 578.74M
SofWave Medical 255.13M
Bait Bakfar 107.78M
Ilex Medical 917.10M
Novolog (Pharm-Up 1966) 1.97B
Geffen Residence & Renewal 84.00K
Revenue Rankings

BrainsWay News

More News